Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1Phase 1/2 1

Status

Completed 59Active not recruiting 35Recruiting 33Unknown 26Terminated 25Withdrawn 16Not yet recruiting 5Approved for marketing 2

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Gynecologic 2CNS 1Breast 1

Conditions

Ovarian Neoplasms 1Metastatic Breast Cancer in Germline-PALB2 Mutations Carriers 1Glioma 1Efficacy 1Advanced Ovarian Cancer 1

Interventions

Cisplatin 122Carboplatin 121Drug Therapy 118Bevacizumab 105Capecitabine 99Oxaliplatin 97Radiotherapy 95Paclitaxel 88Gemcitabine 88tislelizumab 87Cyclophosphamide 86Specimen Handling 80pembrolizumab 76toripalimab 67Magnetic Resonance Spectroscopy 65Fluorouracil 62sintilimab 59Injections 57Surgical Procedures, Operative 56Docetaxel 54anlotinib 51130-nm albumin-bound paclitaxel 48Immune Checkpoint Inhibitors 47fludarabine 46Standard of Care 45Pemetrexed 43Blood Specimen Collection 43Biopsy 43venetoclax 41lenvatinib 41

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Not yet recruiting × niraparib × Clear all
NCT07059676 2025-07-11

LIBINI-1

Clinica Universidad de Navarra, Universidad de Navarra

Not yet recruiting
120 enrolled
Gynecologic

Advanced Ovarian Cancer

NCT06887933 2025-03-21

A Trial to Evaluate the Safety of Niraparib Tablets in Adult Female Participants With Advanced or Relapsed Epithelial Ovarian Cancer

GlaxoSmithKline

Phase 4 Not yet recruiting
67 enrolled
Gynecologic

Ovarian Neoplasms

NCT06258018 2024-08-30

ONC-2022-001

Istituto Clinico Humanitas

Phase 1/2 Not yet recruiting
86 enrolled
CNS

Glioma

NCT06237205 2024-02-01

Genome-Based Assessment of Niraparib (ZEJULA®) Efficacy in Advanced Solid TumorS With Homologous Recombination Deficiency

Korea University Anam Hospital

Phase 2 Not yet recruiting
33 enrolled

Efficacy

NCT05232006 2022-03-08

PALB2-PARPi-01

Assistance Publique - Hôpitaux de Paris

Phase 2 Not yet recruiting
12 enrolled
Breast

Metastatic Breast Cancer in Germline-PALB2 Mutations Carriers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡